Related Experiment Video
Updated: Feb 18, 2026

11:42
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
12.2K
Major bleeding disorders: diagnosis, classification, management and recent developments in haemophilia
Neha Bhatnagar1, Georgina W Hall1
1Paediatric Haematology, Children's Hospital, John Radcliffe Hospital, Oxford, UK.
Archives of Disease in Childhood
|November 28, 2017
Summary
Standard care for paediatric haemophilia in the UK improves quality of life. New therapies promise even better, easier, and personalised prophylaxis for children with this bleeding disorder.
Area of Science:
- Paediatric Haematology
- Bleeding Disorders Management
- Medical Therapy Advancements
Background:
- Haemophilia is the most common major bleeding disorder in children.
- Current standard of care in the UK involves specialist medical care, safer factor concentrates, early prophylaxis, and patient education.
- These measures have enabled patients to achieve good joint function and quality of life into adulthood.
Purpose of the Study:
- To review the current standard of care for paediatric haemophilia in the UK.
- To highlight new therapeutic developments in haemophilia treatment.
- To discuss the potential of these advancements to improve patient outcomes and quality of life.
Main Methods:
- Review of current clinical practices and literature on paediatric haemophilia management in the UK.
- Analysis of emerging therapeutic strategies and their potential impact.
- Discussion of patient-specific education and its role in prophylaxis.
Main Results:
- The current standard of care has led to significant improvements in joint function and quality of life for individuals with haemophilia.
- New therapeutic developments are emerging that offer the potential for enhanced prophylaxis.
- These advancements aim to provide easier and more personalized treatment options.
Conclusions:
- The current management of paediatric haemophilia in the UK provides a strong foundation for patient well-being.
- Exciting new therapies are on the horizon, poised to further revolutionize treatment.
- The future of paediatric haemophilia care focuses on achieving optimal, personalized, and less burdensome prophylaxis.
Related Concept Videos
Disorders of Hemostasis
2.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.3K
Esophageal Varices-II: Clinical Features and Management
626
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
626
Venous Thrombosis IV: Nursing Management
278
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
278
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Introduction to Hemostasis
14.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.9K
Venous Thrombosis III: Interprofessional Care
388
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388

